Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbon Monoxide SCHEMBL3003258 | 0.81 | CTSD (0.31) | CTSD | |
| SCHEMBL2230540 | 0.73 | CTSD (0.43) | CTSD | |
| Hydrochloric Acid SCHEMBL7869576 | 0.67 | CTSD (0.35) | CTSD | |
| Hydrochloric Acid SCHEMBL29987449 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL7637469 | 0.65 | — | — | |
| SCHEMBL28961651 | 0.65 | CTSD (0.38) | CTSD | |
| Hydrochloric Acid SCHEMBL9247457 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL20567259 | 0.65 | CTSD (0.39) | CTSD | |
| Hydrochloric Acid SCHEMBL22660514 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL1539601 | 0.65 | CTSD (0.33) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114057544-B | Method for preparing nerol and geraniol from citral | 万华化学集团股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-11506975-B2 | Photoresist material, method of fabcricating same, and color filter substrate | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2022-11-22 | — | — | US | claimed |
| CN-114752055-A | Para-nitrocinnamic acid modified rapid-reaction associative thickener and preparation method and application thereof | 华南理工大学 | 2022-07-15 | — | — | CN | claimed |
| CN-114057544-A | Method for preparing nerol and geraniol from citral | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-109647524-B | Catalyst and application thereof in production of citronellal and/or citronellol from citral | 万华化学集团股份有限公司 | 2021-10-19 | — | — | CN | claimed |
| US-20210216011-A1 | PHOTORESIST MATERIAL, METHOD OF FABCRICATING SAME, AND COLOR FILTER SUBSTRATE | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2021-07-15 | — | — | US | claimed |
| CN-111072691-A | Photoresist material, preparation method thereof and color film substrate | TCL华星光电技术有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-110922298-A | Method for preparing geraniol from citral | 万华化学集团股份有限公司 | 2020-03-27 | — | — | CN | claimed |
| US-6323303-B1 | POLYMERIZING DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE PRESENCE OF A RUTHENIUM (II) OR RUTHENIUM (III) COMPOUND OR COMPLEX; OPTIONALLY IN PRESENCE OF A TETRAALKYL AMMONIUM OR TETRAALKYL PHOSPHONIUM SALT | GENERAL ELECTRIC COMPANY | 2001-11-27 | — | — | US | claimed |
| US-12497516-B2 | Water-soluble polymeric dyes having pendant chromophores | BECTON, DICKINSON AND COMPANY (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4600734-A1 | PATTERN FORMING METHOD AND LAMINATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2025-08-13 | — | — | EP | disclosed |
| EP-3609527-B1 | PROTEIN CONJUGATES | POLARIS GROUP (KY) | 2025-07-30 | — | — | EP | disclosed |
| US-12344645-B2 | Protein conjugates | POLARIS GROUP (KY) | 2025-07-01 | — | — | US | disclosed |
| EP-3344659-B1 | MOLECULAR CONSTRUCTS FOR PREVENTING THE FORMATION OF BLOOD CLOT AND/OR TREATING THROMBOSIS | IMMUNWORK INC (TW) | 2025-03-26 | — | — | EP | disclosed |
| US-20130183368-A1 | P97-ANTIBODY CONJUGATES AND METHODS OF USE | BIOASIS TECHNOLOGIES, INC. (CA) | 2013-07-18 | — | — | US | disclosed |
| WO-2013053372-A1 | BORONIC ACID INHIBITORS OF BETA-LACTAMASES | THERABOR PHARMACEUTICALS (IT) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013041106-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS 11CO FOR CARBONYLATION REACTIONS IN THE PREPARATION OF RADIOPHARMACEUTICALS FOR PET IMAGING | AARHUS UNIVERSITET (DK) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013006706-A1 | P97-ANTIBODY CONJUGATES AND METHODS OF USE | BIOASIS TECHNOLOGIES INC. (CA) | 2013-01-10 | — | — | WO | disclosed |
| WO-2012079583-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS | AARHUS UNIVERSITET (DK) | 2012-06-21 | — | — | WO | disclosed |
| US-6323303-B1 | POLYMERIZING DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE PRESENCE OF A RUTHENIUM (II) OR RUTHENIUM (III) COMPOUND OR COMPLEX; OPTIONALLY IN PRESENCE OF A TETRAALKYL AMMONIUM OR TETRAALKYL PHOSPHONIUM SALT | GENERAL ELECTRIC COMPANY | 2001-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130183368-A1 | P97-ANTIBODY CONJUGATES AND METHODS OF USE | ERBB2, EGFR, ERBB3 | CTSD 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.